Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. [PDF]
Mungmunpuntipantip R, Wiwanitkit V.
europepmc +1 more source
SERVOVENTILAÇÃO NA DOENÇA CARDIOVASCULAR
Catarina Lacerda +6 more
doaj +1 more source
Impact of Serum Uric Acid Concentration on the Risk of Cardiovascular Disease: A Cohort Study Conducted in Northern China. [PDF]
Nie Q +7 more
europepmc +1 more source
Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients. [PDF]
Sonkar SK +5 more
europepmc +1 more source
Acute Myocardial Infarction with Coronary Thrombosis in a Covid-19 Patient without Risk Factors for Cardiovascular Disease. [PDF]
Viana T +7 more
europepmc +1 more source
Racionalidade e métodos: registro da prática clínica em pacientes de alto risco cardiovascular
FUNDAMENTO: Até o momento, nenhum registro brasileiro foi desenhado para documentar a prática clínica em relação ao atendimento de pacientes de alto risco cardiovascular em uma representativa e ampla amostra de centros investigadores, incluindo hospitais
Luiz Alberto Piva e Mattos
doaj
Pharmacogenomics and Cardiovascular Disease: Where are We and Where do We go from Here? [PDF]
Stein R, Beuren T, Cela LR, Ferrari F.
europepmc +1 more source
Spirituality and Cardiovascular Disease: Valuing Cultural Sensitivity in Cardiology. [PDF]
Lucchetti G.
europepmc +1 more source
[Real-world evidence on pharmacological appropriateness in type 2 diabetes mellitus and cardiovascular disease]. [PDF]
Pintos C +5 more
europepmc +1 more source
Alcohol Consumption and Its Association with Lifestyle in Individuals with and without Cardiovascular Disease. [PDF]
Godoy PH.
europepmc +1 more source

